Loading…
Laxmi Dental (LAXMIDENTL)₹204.51−0.12%Medical Equipment & Supplies
In the Jun 2026 quarter (consolidated), Laxmi Dental reported sales of ₹74.95 Cr, up 13.6% from Jun 2025, and net profit of ₹10.03 Cr, up 24.9% year on year. For the year to Mar 2026, sales were ₹278 Cr and net profit ₹29.10 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 47.95 | 54.95 | 59.96 | 56.99 | 61.98 | 60.98 | 65.96 | 71.91 | 65.95 | 73.92 | 74.95 |
| Expenses | 44.17 | 43.18 | 46.15 | 48.22 | 52.22 | 51.18 | 54.24 | 61.27 | 59.23 | 60.21 | 60.23 |
| Operating Profit | 4.02 | 12.04 | 14.04 | 9.03 | 10.03 | 10.03 | 12.04 | 11.03 | 7.02 | 14.04 | 14.04 |
| OPM % | 8.0% | 21.0% | 23.0% | 14.9% | 15.9% | 15.9% | 17.9% | 14.9% | 10.9% | 17.9% | 18.9% |
| Other Income | 0.00 | 0.00 | 6.01 | 1.01 | 0.99 | 2.01 | 2.01 | 2.01 | −4.01 | 1.99 | 2.01 |
| Interest | 1.01 | 1.01 | 1.01 | 1.01 | 2.01 | 1.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 2.99 | 3.01 | 3.01 | 3.01 | 3.99 | 3.99 | 3.99 | 3.99 | 4.01 | 3.99 | 3.99 |
| Profit before tax | −0.99 | 6.99 | 15.98 | 4.99 | 4.99 | 6.01 | 9.99 | 8.99 | −1.01 | 10.99 | 11.99 |
| Tax % | −140.1% | 15.9% | 10.9% | 22.9% | 23.0% | 41.0% | 24.0% | 20.0% | −175.0% | 4.0% | 21.0% |
| Exceptional items | −0.57 | −0.72 | 5.20 | 0.00 | 0.00 | 0.25 | 0.00 | 0.00 | −3.90 | 0.00 | 0.00 |
| Net Profit | 2.01 | 8.02 | 17.04 | 6.02 | 5.01 | 4.01 | 8.03 | 9.03 | 2.01 | 10.04 | 10.03 |
| EPS (Rs) | 73.85 | 243.29 | 6.02 | 2.11 | 0.92 | 0.77 | 1.52 | 1.54 | 0.35 | 1.82 | 1.86 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|
| Sales | 150 | 91.96 | 137 | 162 | 194 | 239 | 278 | 287 |
| Expenses | 146 | 88.37 | 130 | 153 | 170 | 197 | 235 | 241 |
| Operating Profit | 3.01 | 4.01 | 7.02 | 9.04 | 24.09 | 43.13 | 43.12 | 46.13 |
| OPM % | 2.3% | 4.6% | 4.8% | 6.0% | 13.0% | 17.9% | 15.9% | 16.1% |
| Other Income | 1.99 | 0.00 | −10.01 | 2.01 | 0.00 | 10.01 | 2.99 | 2.00 |
| Interest | 3.01 | 3.01 | 4.02 | 4.02 | 6.02 | 6.02 | 1.01 | 0.00 |
| Depreciation | 7.01 | 5.99 | 8.01 | 10.99 | 12.01 | 14.99 | 15.99 | 15.98 |
| Profit before tax | −3.99 | −3.99 | −16.01 | −4.99 | 6.99 | 31.01 | 28.98 | 30.96 |
| Tax % | 5.0% | 8.0% | 15.0% | 4.0% | −136.1% | 21.0% | 9.0% | — |
| Exceptional items | −1.39 | −3.84 | −9.54 | −0.36 | 0.00 | 5.60 | −4.47 | −3.90 |
| Net Profit | −5.02 | −5.01 | −19.07 | −4.01 | 25.07 | 32.11 | 29.10 | 31.11 |
| EPS (Rs) | −154.55 | −155.92 | −595.58 | −128.57 | 802.75 | 5.77 | 5.26 | 5.57 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.30 | 0.30 | 0.30 | 0.30 | 0.30 | 10.96 | 10.96 |
| Reserves | 36.94 | 32.96 | 8.98 | 5.98 | 30.97 | 198 | 232 |
| Borrowings | 36.99 | 38.96 | 49.92 | 49.94 | 60.94 | 19.98 | 12.97 |
| Other Liabilities | 30.85 | 33.83 | 42.79 | 39.81 | 45.82 | 59.71 | 37.81 |
| Total Liabilities | 106 | 106 | 103 | 96.72 | 139 | 287 | 293 |
| Fixed Assets | 38.87 | 41.87 | 39.83 | 39.85 | 45.81 | 50.81 | 62.77 |
| CWIP | 0.00 | 6.99 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 5.99 | 9.98 | 26.95 |
| Other Assets | 65.90 | 55.88 | 62.85 | 55.87 | 86.92 | 226 | 204 |
| Inventories | 18.98 | 24.97 | 29.97 | 23.94 | 28.93 | 21.95 | 21.98 |
| Trade receivables | 26.04 | 16.02 | 20.04 | 20.05 | 25.06 | 37.10 | 46.07 |
| Cash & equivalents | 1.99 | 1.99 | 0.99 | 1.99 | 0.99 | 109 | 9.97 |
| Total Assets | 106 | 106 | 103 | 96.72 | 139 | 287 | 293 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from operating activity | 11.96 | 9.97 | −1.99 | 13.96 | 7.97 | 43.87 | −4.98 |
| Cash from investing activity | −18.01 | −9.01 | 3.01 | −10.02 | −11.01 | −29.03 | −80.08 |
| Cash from financing activity | 6.01 | 0.00 | −4.01 | −1.01 | −3.01 | 111 | −18.02 |
| Net cash flow | 0.00 | 0.00 | −3.01 | 3.01 | −5.01 | 125 | −102 |
| Capex | 17.05 | 9.03 | 10.04 | 10.02 | 15.05 | 16.05 | 18.04 |
| Free cash flow | −5.01 | 0.00 | 0.00 | 5.01 | −5.01 | 28.03 | −23.03 |
| CFO / OP % | 357.0% | 225.9% | −30.0% | 156.9% | 37.9% | 109.0% | 4.0% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor days | 64 | 64 | 54 | 46 | 47 | 56 | 60 |
| Inventory days | 186 | 305 | 272 | 212 | — | 397 | 97 |
| Days payable | 197 | 273 | 245 | 197 | — | 585 | 47 |
| Cash conversion cycle | 54 | 96 | 81 | 61 | 47 | −132 | 109 |
| Working capital days | 13 | 3 | −3 | −13 | 0 | 37 | 195 |
| ROCE % | — | 3.0% | −1.0% | 1.0% | 18.0% | 19.0% | 15.0% |
For the Jun 2026 quarter, Laxmi Dental reported sales of ₹74.95 Cr, up 13.6% year on year and net profit of ₹10.03 Cr, up 24.9% year on year. The operating margin was 18.9%.
Laxmi Dental's sales for the year to Mar 2026 were ₹278 Cr; over the last twelve months they were ₹287 Cr.
Net profit for the year to Mar 2026 was ₹29.10 Cr, and ₹31.11 Cr over the last twelve months. Earnings per share over the same trailing period were ₹5.57.
Laxmi Dental reported borrowings of ₹12.97 Cr at Mar 2026, against cash and equivalents of ₹9.97 Cr.
Cash from operations was −₹4.98 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹23.03 Cr.